Cas:76060-35-0 [6]-Dehydrogingerdione manufacturer & supplier

We serve Chemical Name:[6]-Dehydrogingerdione CAS:76060-35-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

[6]-Dehydrogingerdione

Chemical Name:[6]-Dehydrogingerdione
CAS.NO:76060-35-0
Synonyms:1-Decene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-;1-(4-Hydroxy-3-methoxyphenyl)-1-decene-3,5-dione;[6]-Dehydrogingerdione;1-Dehydro-6-gingerdione
Molecular Formula:C17H22O4
Molecular Weight:290.35400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:448.9±40.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.546
PSA:63.60000
Exact Mass:290.15200
LogP:3.52260

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-Decene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Dehydro-6-gingerdione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Dehydro-6-gingerdione Use and application,1-Decene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)- technical grade,usp/ep/jp grade.


Related News: Charles River looks forward to continuing its ongoing partnership with AstraZeneca. It was great to join the team today, to see the facility for myself and congratulate them on this really significant expansion, which will see an €8m investment, creating 90 new jobs for Mayo. Z-Val-pGlu-NH2 manufacturers One of the engineered IgM antibodies, IGM-6268, demonstrated a significantly increased potency against the original SARS-CoV-2 and emerging variants such as the current U.K., South African, and Brazilian variants of concern (VOC) and variants of interest (VOI) 3-(2-((1-methyl-4-(3,5-dimethylphenyl)piperidin-4-yl)carbamoyl)-4-(2,5-difluorophenoxymethyl)phenyl)propanoic acid suppliers Case in point: Hansoh Pharma is seeking approvals for its third-generation EGFR inhibitor Ameile (almonertinib) for newly diagnosed EGFR-mutated non-small cell lung cancer. (E)-N-(2-(4-acetamidophenoxy)benzyl)-2-(1-(3-(4-cyanophenyl)allyl)piperidin-4-yl)acetamide hydrochloride vendor & factory.